5.9(top 5%)
impact factor
17.7K(top 1%)
papers
603.4K(top 1%)
citations
233(top 1%)
h-index
6.2(top 5%)
impact factor
19.4K
all documents
619.3K
doc citations
332(top 1%)
g-index

Top Articles

#TitleJournalYearCitations
1From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid TumorsJournal of Nuclear Medicine20093,047
2Partial-Volume Effect in PET Tumor ImagingJournal of Nuclear Medicine20071,227
3A combined PET/CT scanner for clinical oncologyJournal of Nuclear Medicine20001,022
4Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitutionJournal of Nuclear Medicine1986993
5Recommendations on the Use of 18F-FDG PET in OncologyJournal of Nuclear Medicine2008978
6OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicineJournal of Nuclear Medicine2005914
7Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical ProstatectomyJournal of Nuclear Medicine2015907
868Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of CancerJournal of Nuclear Medicine2019874
968Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CTJournal of Nuclear Medicine2007859
10Performance Measurements of the Siemens mMR Integrated Whole-Body PET/MR ScannerJournal of Nuclear Medicine2011828
11Automatic quantification of ejection fraction from gated myocardial perfusion SPECTJournal of Nuclear Medicine1995781
12Brain blood flow measured with intravenous H2(15)O. II. Implementation and validationJournal of Nuclear Medicine1983768
13Skeletal PET with18F-Fluoride: Applying New Technology to an Old TracerJournal of Nuclear Medicine2008746
14225Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate CancerJournal of Nuclear Medicine2016741
15Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiographyJournal of Nuclear Medicine1992739
16Standards for PET Image Acquisition and Quantitative Data AnalysisJournal of Nuclear Medicine2009720
17A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PETJournal of Nuclear Medicine1995686
18Introduction to RadiomicsJournal of Nuclear Medicine2020673
19Tissue Classification as a Potential Approach for Attenuation Correction in Whole-Body PET/MRI: Evaluation with PET/CT DataJournal of Nuclear Medicine2009663
20German Multicenter Study Investigating177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer PatientsJournal of Nuclear Medicine2017646
21Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other DementiasJournal of Nuclear Medicine2008637
22Brain blood flow measured with intravenous H2(15)O. I. Theory and error analysisJournal of Nuclear Medicine1983634
23MIRD Pamphlet No. 21: A Generalized Schema for Radiopharmaceutical Dosimetry—Standardization of NomenclatureJournal of Nuclear Medicine2009633
24Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal CancerJournal of Nuclear Medicine2011626
25In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18)Journal of Nuclear Medicine2010607
26Correction for partial volume effects in PET: principle and validationJournal of Nuclear Medicine1998602
27A tabulated summary of the FDG PET literatureJournal of Nuclear Medicine2001594
28The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CTJournal of Nuclear Medicine2006577
29Causes and Consequences of Increased Glucose Metabolism of CancersJournal of Nuclear Medicine2008560
30The applications of PET in clinical oncologyJournal of Nuclear Medicine1991542
31Benefit of Time-of-Flight in PET: Experimental and Clinical ResultsJournal of Nuclear Medicine2008530
32Tumor pH and Its MeasurementJournal of Nuclear Medicine2010528
33Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation ProteinJournal of Nuclear Medicine2018522
34Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute TrialsJournal of Nuclear Medicine2006522
35Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted TherapyJournal of Nuclear Medicine2015516
36Neuroinflammation in Schizophrenia-Related Psychosis: A PET StudyJournal of Nuclear Medicine2009515
37PET/MRI Dual-Modality Tumor Imaging Using Arginine-Glycine-Aspartic (RGD)–Conjugated Radiolabeled Iron Oxide NanoparticlesJournal of Nuclear Medicine2008507
38SUV: standard uptake or silly useless value?Journal of Nuclear Medicine1995507
39Multimodality Molecular Imaging of Tumor AngiogenesisJournal of Nuclear Medicine2008497
40MRI-Based Attenuation Correction for PET/MRI Using Ultrashort Echo Time SequencesJournal of Nuclear Medicine2010497
41EANM/SNMMI Guideline for18F-FDG Use in Inflammation and InfectionJournal of Nuclear Medicine2013496
42PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617Journal of Nuclear Medicine2016475
43Total-Body PET: Maximizing Sensitivity to Create New Opportunities for Clinical Research and Patient CareJournal of Nuclear Medicine2018474
4468Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various CancersJournal of Nuclear Medicine2019468
45First Clinical Experience with Integrated Whole-Body PET/MR: Comparison to PET/CT in Patients with Oncologic DiagnosesJournal of Nuclear Medicine2012466
46Ventilation-Perfusion Scintigraphy Is More Sensitive than Multidetector CTPA in Detecting Chronic Thromboembolic Pulmonary Disease as a Treatable Cause of Pulmonary HypertensionJournal of Nuclear Medicine2007459
47Molecular Imaging of HypoxiaJournal of Nuclear Medicine2008455
48A Tumor-Imaging Method Targeting Cancer-Associated FibroblastsJournal of Nuclear Medicine2018453
49First Human Imaging Studies with the EXPLORER Total-Body PET Scanner*Journal of Nuclear Medicine2019453
50Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate CancerJournal of Nuclear Medicine2015451